| Financial Year |
March 31 2023 |
| Monetary Funds |
1,325,899,175.56 |
| Held-for-trading Financial Assets |
43,633.04 |
| Notes Receivable |
520,963,073.84 |
| Accounts Receivable |
627,207,439.17 |
| Advances to Suppliers |
89,200,897.71 |
| Other Receivables |
59,547,440.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,148,800,707.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
63,595,055.22 |
| Total Current Assets |
3,924,206,144.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
736,643,820.12 |
| Investment Properties |
-- |
| Fixed Assetes |
4,317,576,398.81 |
| Under-construction Projects |
132,001,092.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
381,150,704.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,392,828.70 |
| Deferred Income Tax Assets |
133,392,730.77 |
| Other Non-Current Assets |
29,973,259.88 |
| Sub-Total of Non-Current Assets |
5,750,123,140.61 |
| Total Assets |
9,674,329,284.74 |
| Short-Term Loans |
3,523,381,131.41 |
| Trading Financial liabilities |
1,998,452.72 |
| Notes Payable |
442,735,319.53 |
| Accounts Payable |
861,434,162.46 |
| Accounts Received In Advance |
2,508,300.04 |
| Employee Compensation Payable |
96,915,097.20 |
| Taxes Payable |
7,475,525.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
175,253,876.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
434,282,082.96 |
| Other Current Liabilities |
308,652,805.72 |
| Sub-Total of Current Liabilities |
6,020,441,437.18 |
| Long-term Loans |
1,076,250,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
38,388,955.96 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,390,595.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,524,223,420.63 |
| Total Liabilities |
7,544,664,857.81 |
| Paid-In Capital(Or Share Stock) |
816,792,487.00 |
| Capital Surplus |
1,873,542,457.92 |
| Surplus Reserve |
63,736,427.75 |
| LESS:Treasury Stock |
104,185.00 |
| Undistributed Profits |
-555,355,198.24 |
| Minority Stockholder's Interest |
-106,424,318.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,236,088,745.79 |
| Owner's Equity（Stockholder's Equity） |
2,129,664,426.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,674,329,284.74 |
